Levels of ll-37 antimicrobial peptide in the gingival crevicular fluid of young and middle-aged subjects with or without gingivitis
- PMID: 28955581
- PMCID: PMC5573490
- DOI: 10.17096/jiufd.42354
Levels of ll-37 antimicrobial peptide in the gingival crevicular fluid of young and middle-aged subjects with or without gingivitis
Abstract
Purpose: LL-37 is an antimicrobial peptide which plays an important role in the innate immunity. The aim of this study was to investigate the LL-37 levels in the gingival crevicular fluid (GCF) of middle-aged and young adults who have either gingivitis or healthy periodontal tissues.
Materials and methods: Forty middle-aged adults (20 healthy controls and 20 with gingivitis) and 41 younger adults (20 healthy controls and 21 with gingivitis) were included in the present study. Probing depth, clinical attachment level, plaque index, and papilla bleeding index were recorded. LL-37 levels in the GCF were analyzed by enzyme-linked immunosorbent assay.
Results: No significant differences were observed in the GCF LL-37 levels between young healthy and middle-aged healthy subjects. Also, there were no significant differences in GCF LL-37 levels between young and middle-aged gingivitis subjects. However, gingivitis groups had significantly higher GCF LL-37 levels than healthy groups (p<0.001). Correlation analysis demonstrated no significant correlation between age and GCF LL-37 levels neither in healthy nor in gingivitis groups.
Conclusion: The levels of LL-37 in GCF increase in the presence of gingival inflammation, however, this does not vary according to subjects being young or middle-aged.
Keywords: Cathelicidin LL-37; age; antimicrobial peptide; gingival crevicular fluid; gingivitis.
Conflict of interest statement
Conflict of interest: None declared.
Similar articles
-
Gingival crevicular fluid levels of cathelicidin LL-37 and interleukin-18 in patients with chronic periodontitis.J Periodontol. 2009 Jun;80(6):969-76. doi: 10.1902/jop.2009.080532. J Periodontol. 2009. PMID: 19485828
-
Gingival crevicular fluid and serum hCAP18/LL-37 levels in generalized aggressive periodontitis.Clin Oral Investig. 2017 Apr;21(3):763-769. doi: 10.1007/s00784-016-1834-z. Epub 2016 Apr 30. Clin Oral Investig. 2017. PMID: 27129587
-
Evaluation of gingival crevicular fluid adrenomedullin and human neutrophil peptide 1-3 levels of patients with different periodontal diseases.J Periodontol. 2010 Feb;81(2):284-91. doi: 10.1902/jop.2009.090517. J Periodontol. 2010. PMID: 20151808
-
Evaluation of p53, bcl-2, and interleukin-15 levels in gingival crevicular fluid of cyclosporin A-treated patients.J Periodontol. 2003 Apr;74(4):506-11. doi: 10.1902/jop.2003.74.4.506. J Periodontol. 2003. PMID: 12747456
-
Cathelicidin LL-37 in periodontitis: current research advances and future prospects - A review.Int Immunopharmacol. 2025 Mar 26;150:114277. doi: 10.1016/j.intimp.2025.114277. Epub 2025 Feb 15. Int Immunopharmacol. 2025. PMID: 39954662 Review.
Cited by
-
Natural Antimicrobial Peptides and Their Synthetic Analogues for Effective Oral Microflora Control and Oral Infection Treatment-The Role of Ceragenins in the Development of New Therapeutic Methods.Pharmaceuticals (Basel). 2024 Dec 20;17(12):1725. doi: 10.3390/ph17121725. Pharmaceuticals (Basel). 2024. PMID: 39770567 Free PMC article. Review.
-
Positive correlational shift between crevicular antimicrobial peptide LL-37, pain and periodontal status following non-surgical periodontal therapy. A pilot study.BMC Oral Health. 2023 May 28;23(1):335. doi: 10.1186/s12903-023-03023-w. BMC Oral Health. 2023. PMID: 37246231 Free PMC article.
References
-
- Heasman PA, Collins JG, Offenbacher S. Changes in crevicular fluid levels of interleukin-1 beta, leukotriene b4, prostaglandin e2, thromboxane b2 and tumour necrosis factor alpha in experimental gingivitis in humans. J Periodontal Res. 1993;28(4):241–247. doi: 10.1111/j.1600-0765.1993.tb02090.x. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources